Louise Francesconi - 28 Jun 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director
Signature
/s/ David Patience, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
28 Jun 2024
Net transactions value
$0
Form type
4
Filing time
01 Jul 2024, 18:31:24 UTC
Previous filing
30 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +4,737 +16% $0.000000 33,558 28 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Restricted Stock Units Options Exercise $0 -4,737 -20% $0.000000 18,947 28 Jun 2024 Common Stock 4,737 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2 On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024.